Cargando…
The Effects of Antimicrobial Peptide Nal-P-113 on Inhibiting Periodontal Pathogens and Improving Periodontal Status
Periodontal disease consists of chronic gingival inflammation characterized by both degradation of the periodontal connective tissue and alveolar bone loss. Drug therapy is used as an auxiliary treatment method in severe chronic periodontitis, aggressive periodontitis, and periodontitis-associated s...
Autores principales: | Wang, Hongyan, Ai, Lisi, Zhang, Yu, Cheng, Jyawei, Yu, Huiyuan, Li, Chen, Zhang, Dongmei, Pan, Yaping, Lin, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875022/ https://www.ncbi.nlm.nih.gov/pubmed/29736391 http://dx.doi.org/10.1155/2018/1805793 |
Ejemplares similares
-
The Antimicrobial Peptide Nal-P-113 Exerts a Reparative Effect by Promoting Cell Proliferation, Migration, and Cell Cycle Progression
por: Liu, Nana, et al.
Publicado: (2018) -
Preventive effects of the novel antimicrobial peptide Nal-P-113 in a rat Periodontitis model by limiting the growth of Porphyromonas gingivalis and modulating IL-1β and TNF-α production
por: Wang, Hong-yan, et al.
Publicado: (2017) -
Molecular pathways underlying inhibitory effect of antimicrobial peptide Nal-P-113 on bacteria biofilms formation of Porphyromonas gingivalis W83 by DNA microarray
por: Wang, Hong-yan, et al.
Publicado: (2017) -
Assessment of Alveolar Bone Status in Middle Aged Chinese (40-59 Years) with Chronic Periodontitis — Using CBCT
por: Zhao, Haijiao, et al.
Publicado: (2015) -
Activity of five antimicrobial peptides against periodontal as well as non-periodontal pathogenic strains
por: Enigk, Katharina, et al.
Publicado: (2020)